Tetrahydrofuran

Tetrahydrofuran

SCHEMBL8375806

C1CCOC1.O=C(O)CCCCCCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.63
LMNA P02545 3/20 0.63
NFKB1 P19838 1/20 0.63
PMP22 Q01453 1/20 0.63
GPR84 Q9NQS5 8/20 0.52
FFAR1 O14842 2/20 0.52
FFAR4 Q5NUL3 2/20 0.52
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
ALDH1A1 P00352 4/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 2/20 0.50
FABP4 P15090 2/20 0.50
ALOX15 P16050 2/20 0.50
PTPN1 P18031 2/20 0.50
KMT2A Q03164 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL8379357 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL27554023 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL27554024 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Tetrahydrofuran SCHEMBL8376671 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Tetrahydrofuran SCHEMBL8375061 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Tetrahydrofuran SCHEMBL8376666 1.00 TSHR (0.63) TSHRLMNANFKB1PMP22GPR84
Adipic Acid SCHEMBL1638937 0.97 LMNA (0.61) TSHRLMNANFKB1PMP22GPR84
Adipic Acid SCHEMBL28032942 0.97 LMNA (0.61) TSHRLMNANFKB1PMP22GPR84
Adipic Acid SCHEMBL25247249 0.89 LMNA (0.65) TSHRLMNANFKB1PMP22GPR84
Adipic Acid SCHEMBL7544486 0.89 LMNA (0.65) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36359-E SUCH AS N-(15-CARBOXYPENTADECANOYLOXY)SUCCINIMIDE; USED TO MODIFY PROTEINS TO OBTAIN PROTEIN DERIVATIVES HAVING IMPROVED BIOAVAILABILITY, NO ANTIGENICITY AND CAN BE ADMINISTERED TO ANIMALS KURARAY CO., LTD. (JP) 1999-10-26 US disclosed
EP-0511600-B1 Long chain carboxylic acid imide ester KURARAY CO (JP) 1999-03-17 EP disclosed
US-5414089-A Useful for modifying enzymes or proteins KURARAY CO., LTD. (JP) 1995-05-09 US disclosed
US-5336782-A N-(carboxyalkoyloxy)succinimides; modifiers of proteins and enzymes to prolong their plasma half-lives; nontoxic; antitumor and -carcinogenic agents KURARAY CO., LTD. (JP) 1994-08-09 US disclosed
EP-0511600-A2 Long chain carboxylic acid imide ester KURARAY CO., LTD. (JP) 1992-11-04 EP disclosed